Levodropropizine
- Generic Name
- Levodropropizine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C13H20N2O2
- CAS Number
- 99291-25-5
- Unique Ingredient Identifier
- 3O31P6T4G3
- Background
Levodropropizine is under investigation in clinical trial NCT01573663 (A Drug-Drug Interaction Study of Ambroxol and Levodropropizine).
- Associated Conditions
- Cough
- Associated Therapies
- -
The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-02-09
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- University Hospital Hradec Kralove
- Target Recruit Count
- 102
- Registration Number
- NCT06252454
- Locations
- 🇨🇿
Plicnà klinika, Fakultni nemocnice Hradec Kralove, Hradec Králové, Czechia
A Drug-Drug Interaction Study of Ambroxol and Levodropropizine
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-04-09
- Last Posted Date
- 2012-07-19
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 21
- Registration Number
- NCT01573663
- Locations
- 🇰🇷
Samsung medical center, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath